Skip to main content
Download PDF
  • Retraction Note
  • Open access
  • Published:

Retraction note: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues

Diagnostic Pathology volume 11, Article number: 105 (2016) Cite this article

The Original Article was published on 07 August 2015

Retraction

The Editor-in-Chief and Publisher have retracted this article [1] because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2, 3]) and authorship manipulation.

References

  1. Ajdarkosh H, Dadpay M, Yahaghi E, Pirzaman ER, Fayyaz AF, Darian EK, Mokarizadeh A. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Diagn Pathol. 2015;10:135.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Zhang SL, Liu L. microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1. Exp Ther Med. 2014;9(2):579–84.

    PubMed  PubMed Central  Google Scholar 

  3. Zhang J-G, Shi Y, Hong D-F, Song M, Huang D, Wang C-Y, Zhao G. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway. Sci Rep. 2015;5:8087.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastrointestinal and Liver Disease Research Center (GILDRC), Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran

    Hossein Ajdarkosh

  2. Department of Pathology, Imam Reza Hospital, AJA University of Medical Sciences, Tehran, Iran

    Masoomeh Dadpay

  3. Baqiyatallah University of Medical Sciences, Tehran, Iran

    Emad Yahaghi

  4. Department of Biotechnology and Nanotechnology, Zanjan University of Medical Sciences, Zanjan, Iran

    Elham Rostami Pirzaman

  5. Department of Legal Medicine, AJA University of Medical Sciences, Tehran, Iran

    Amir Farshid Fayyaz

  6. Young Researchers and Elite Club, Karaj Branch, Islamic Azad University, Karaj, Iran

    Ebrahim Khodaverdi Darian

  7. Cellular & Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran

    Aram Mokarizadeh

Authors
  1. Hossein Ajdarkosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masoomeh Dadpay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emad Yahaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elham Rostami Pirzaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amir Farshid Fayyaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ebrahim Khodaverdi Darian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aram Mokarizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aram Mokarizadeh.

Additional information

The online version of the original article can be found under doi:10.1186/s13000-015-0371-4.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ajdarkosh, H., Dadpay, M., Yahaghi, E. et al. Retraction note: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Diagn Pathol 11, 105 (2016). https://doi.org/10.1186/s13000-016-0561-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13000-016-0561-8

Diagnostic Pathology

ISSN: 1746-1596

Contact us